NCT03894618 2025-04-02SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasShattuck Labs, Inc.Phase 1 Completed49 enrolled 32 charts
NCT05909995 2025-02-18Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsIncyte CorporationPhase 1 Terminated8 enrolled
NCT06034860 2024-11-01Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesMolecular Templates, Inc.Phase 1 Terminated15 enrolled
NCT03652077 2021-11-15A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesIncyte CorporationPhase 1 Completed40 enrolled